236 related articles for article (PubMed ID: 18814951)
1. Gene-expression profiles of peripheral blood mononuclear cell subpopulations in acute graft-vs-host disease following cord blood transplantation.
Takahashi N; Sato N; Takahashi S; Tojo A
Exp Hematol; 2008 Dec; 36(12):1760-1770. PubMed ID: 18814951
[TBL] [Abstract][Full Text] [Related]
2. Profiling of immune-related microRNA expression in human cord blood and adult peripheral blood cells upon proinflammatory stimulation.
Takahashi N; Nakaoka T; Yamashita N
Eur J Haematol; 2012 Jan; 88(1):31-8. PubMed ID: 21913990
[TBL] [Abstract][Full Text] [Related]
3. Cytokine gene expression in peripheral blood mononuclear cells and alloreactivity in hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL; Madsen HO; Ryder LP; Svejgaard A; Dickmeiss E; Vindeløv LL
Biol Blood Marrow Transplant; 2006 Jan; 12(1):48-60. PubMed ID: 16399568
[TBL] [Abstract][Full Text] [Related]
4. Increased gene expression of chemokine receptors is correlated with acute graft-versus-host disease after allogeneic stem cell transplantation.
Jaksch M; Remberger M; Mattsson J
Biol Blood Marrow Transplant; 2005 Apr; 11(4):280-7. PubMed ID: 15812393
[TBL] [Abstract][Full Text] [Related]
5. Tacrolimus and methotrexate for the prophylaxis of graft-versus-host disease after unrelated donor cord blood transplantation for adult patients with hematologic malignancies.
Mori T; Aisa Y; Nakazato T; Yamazaki R; Shimizu T; Mihara A; Yamane A; Ikeda Y; Okamoto S
Transplant Proc; 2007 Jun; 39(5):1615-9. PubMed ID: 17580201
[TBL] [Abstract][Full Text] [Related]
6. Phase I study of high-stringency CD8 depletion of donor leukocyte infusions after allogeneic hematopoietic stem cell transplantation.
Orti G; Lowdell M; Fielding A; Samuel E; Pang K; Kottaridis P; Morris E; Thomson K; Peggs K; Mackinnon S; Chakraverty R
Transplantation; 2009 Dec; 88(11):1312-8. PubMed ID: 19996931
[TBL] [Abstract][Full Text] [Related]
7. Cell cycle and immune-related processes are significantly altered in chronic GVHD.
Oh SJ; Cho SB; Park SH; Piao CZ; Kwon SM; Kim I; Yoon SS; Kim BK; Park EK; Kang JJ; Yang SJ; Lee WJ; Yoo CH; Hwang S; Kim SH; Kim JH; Park S
Bone Marrow Transplant; 2008 Jun; 41(12):1047-57. PubMed ID: 18332912
[TBL] [Abstract][Full Text] [Related]
8. Cord blood transplantation for adult patients with hematological malignancies.
Yamane T; Nakamae H; Hasegawa T; Terada Y; Hagihara K; Ohta K; Hino M
Osaka City Med J; 2005 Dec; 51(2):83-8. PubMed ID: 16617685
[TBL] [Abstract][Full Text] [Related]
9. [Cord blood transplantation].
Takahashi S; Asano S
Gan To Kagaku Ryoho; 2004 Mar; 31(3):307-13. PubMed ID: 15045930
[TBL] [Abstract][Full Text] [Related]
10. B-cell concentration in the apheretic product predicts acute graft-versus-host disease and treatment-related mortality of allogeneic peripheral blood stem cell transplantation.
Iori AP; Torelli GF; De Propris MS; Milano F; Pupella S; Gozzer M; Mancini F; Milani ML; Intoppa S; Cerretti R; Lucarelli B; Valle V; Malandruccolo L; Iannella E; Arleo E; Guarini A; Foà R
Transplantation; 2008 Feb; 85(3):386-90. PubMed ID: 18322430
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes of unrelated donor umbilical cord blood transplantation for 30 adults with hematological malignancies.
Kobayashi K; Maeda Y; Hara Y; Nishie-Kataoka M; Nishimori H; Sugiyama H; Namba N; Kubonishi S; Niiya M; Shinagawa K; Ikeda K; Tanimoto M
Anticancer Res; 2009 May; 29(5):1763-70. PubMed ID: 19443401
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics of chronic graft-versus-host disease following umbilical cord blood transplantation for adults.
Sugimoto K; Narimatsu H; Kawase T; Iida H; Watanabe M; Kohno A; Kuwatsuka Y; Uchida T; Hamaguchi M; Terakura S; Naoe T; Matsuo K; Murata M; Sawa M; Miyamura K; Morishita Y;
Bone Marrow Transplant; 2008 Apr; 41(8):729-36. PubMed ID: 18176617
[TBL] [Abstract][Full Text] [Related]
13. Results of a pilot study on the use of third-party donor mesenchymal stromal cells in cord blood transplantation in adults.
Gonzalo-Daganzo R; Regidor C; Martín-Donaire T; Rico MA; Bautista G; Krsnik I; Forés R; Ojeda E; Sanjuán I; García-Marco JA; Navarro B; Gil S; Sánchez R; Panadero N; Gutiérrez Y; García-Berciano M; Pérez N; Millán I; Cabrera R; Fernández MN
Cytotherapy; 2009; 11(3):278-88. PubMed ID: 19308773
[TBL] [Abstract][Full Text] [Related]
14. Activated circulating dendritic cells after hematopoietic stem cell transplantation predict acute graft-versus-host disease.
Lau J; Sartor M; Bradstock KF; Vuckovic S; Munster DJ; Hart DN
Transplantation; 2007 Apr; 83(7):839-46. PubMed ID: 17460553
[TBL] [Abstract][Full Text] [Related]
15. Activating killer immunoglobulin-like receptor incompatibilities enhance graft-versus-host disease and affect survival after allogeneic hematopoietic stem cell transplantation.
Giebel S; Nowak I; Dziaczkowska J; Czerw T; Wojnar J; Krawczyk-Kulis M; Holowiecki J; Holowiecka-Goral A; Markiewicz M; Kopera M; Karolczyk A; Kyrcz-Krzemien S; Kusnierczyk P
Eur J Haematol; 2009 Oct; 83(4):343-56. PubMed ID: 19500138
[TBL] [Abstract][Full Text] [Related]
16. Myeloablative cord blood transplantation for adults with hematological malignancies using tacrolimus and short-term methotrexate for graft-versus-host disease prophylaxis: single-institution analysis.
Yamada MF; Miyamura K; Fujiwara T; Kohata K; Okitsu Y; Ohguchi H; Yamamoto J; Yokoyama H; Tomiya Y; Ishizawa K; Kameoka J; Harigae H
Transplant Proc; 2008 Dec; 40(10):3637-42. PubMed ID: 19100456
[TBL] [Abstract][Full Text] [Related]
17. Myeloablative unrelated cord blood transplantation for acute leukemia patients between 50 and 55 years of age: single institutional retrospective comparison with patients younger than 50 years of age.
Konuma T; Takahashi S; Ooi J; Tomonari A; Tsukada N; Kato S; Sato A; Monma F; Kasahara S; Nagamura-Inoue T; Uchimaru K; Iseki T; Tojo A; Yamaguchi T; Asano S
Ann Hematol; 2009 Jun; 88(6):581-8. PubMed ID: 19030858
[TBL] [Abstract][Full Text] [Related]
18. Herpes simplex virus infection in adult patients after unrelated cord blood transplantation: a single-institute experience in Japan.
Tomonari A; Takahashi S; Iseki T; Ooi J; Yamada T; Takasugi K; Shimohakamada Y; Ohno N; Nagamura F; Uchimaru K; Tani K; Tojo A; Asano S
Bone Marrow Transplant; 2004 Feb; 33(3):317-20. PubMed ID: 14647249
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation.
Dander E; Balduzzi A; Zappa G; Lucchini G; Perseghin P; Andrè V; Todisco E; Rahal D; Migliavacca M; Longoni D; Solinas G; Villa A; Berti E; Mina PD; Parma M; Allavena P; Biagi E; Rovelli A; Biondi A; D'Amico G
Transplantation; 2009 Dec; 88(11):1261-72. PubMed ID: 19996925
[TBL] [Abstract][Full Text] [Related]
20. Immune reconstitution after cord blood transplants supported by coinfusion of mobilized hematopoietic stem cells from a third party donor.
Martín-Donaire T; Rico M; Bautista G; Gonzalo-Daganzo R; Regidor C; Ojeda E; Sanjuán I; Forés R; Ruiz E; Krsnik I; Navarro B; Gil S; Magro E; Millán I; Sánchez R; Pérez-Sanz N; Panadero N; García-Marco JA; Cabrera R; Fernández MN
Bone Marrow Transplant; 2009 Aug; 44(4):213-25. PubMed ID: 19252533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
